CURIS, INC. Payments to Acquire Long-term Investments
CURIS, INC. (CRIS) reported Payments to Acquire Long-term Investments of $750.00 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireLongtermInvestments · last filed 2012-11-06
- 2012-09-30: Payments to Acquire Long-term Investments 9 month $750.00K.
| Period end | Payments to Acquire Long-term Investments 9 month |
|---|---|
| 2012-09-30 | $750.00K 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |